Assyro AI

Orange Book product · Brand (NDA)

YOSPRALA

ASPIRIN; OMEPRAZOLE

Brand (NDA)NDA 205103DISCN GENUS LIFESCIENCES

At a glance

Sep 14, 2016

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 14, 2016

    9 yr 11 mo ago

  2. Today

  3. Patent 9987231 expires

    Listed method-of-use patent (U-2324) expiration.

    Jan 02, 2033

    in 6 yr 8 mo

  4. Patent 9539214 expires

    Listed method-of-use patent (U-1902) expiration.

    Mar 13, 2033

    in 6 yr 10 mo

Pharmaceutical detail

Active ingredient

ASPIRIN; OMEPRAZOLE

Strength

81MG;40MG

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 205103

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9987231Jan 02, 2033in 6 yr 8 mo
U-2324
9539214Mar 13, 2033in 6 yr 10 mo
U-1902
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.